Global Plasma Protease C1-inhibitor Treatment Market Insights, Forecast to 2025

Publisher Name :
Date: 26-Oct-2018
No. of pages: 118
Inquire Before Buying

In 2017, the global Plasma Protease C1-inhibitor Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Plasma Protease C1-inhibitor Treatment market based on company, product type, application and key regions.This report studies the global market size of Plasma Protease C1-inhibitor Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Plasma Protease C1-inhibitor Treatment in these regions.

This research report categorizes the global Plasma Protease C1-inhibitor Treatment market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Plasma Protease C1-inhibitor Treatment include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Plasma Protease C1-inhibitor Treatment include

- Shire plc

- CSL Limited

- Sanquin

- Pharming Group N.V.

Market Size Split by Type

- by Drug Class

- - C1-inhibitors

- - Kallikrein Inhibitor (Kalbitor)

- - Selective Bradykinin B2 Receptor Antagonist (Firazyr)

- by Dosage Type

- - Liquid/Injectable

- - Lyophilized

Market Size Split by Application

- Hospital Pharmacies

- Independent Pharmacies and Outlets

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Plasma Protease C1-inhibitor Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Plasma Protease C1-inhibitor Treatment market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Plasma Protease C1-inhibitor Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Plasma Protease C1-inhibitor Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Plasma Protease C1-inhibitor Treatment submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Plasma Protease C1-inhibitor Treatment are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Plasma Protease C1-inhibitor Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Plasma Protease C1-inhibitor Treatment Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Plasma Protease C1-inhibitor Treatment Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type
1.4.2 C1-inhibitors
1.4.3 Kallikrein Inhibitor (Kalbitor)
1.4.4 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
1.5 Market by Application
1.5.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies and Outlets
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Plasma Protease C1-inhibitor Treatment Market Size
2.1.1 Global Plasma Protease C1-inhibitor Treatment Revenue 2016-2025
2.1.2 Global Plasma Protease C1-inhibitor Treatment Sales 2016-2025
2.2 Plasma Protease C1-inhibitor Treatment Growth Rate by Regions
2.2.1 Global Plasma Protease C1-inhibitor Treatment Sales by Regions
2.2.2 Global Plasma Protease C1-inhibitor Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Plasma Protease C1-inhibitor Treatment Sales by Manufacturers
3.1.1 Plasma Protease C1-inhibitor Treatment Sales by Manufacturers
3.1.2 Plasma Protease C1-inhibitor Treatment Sales Market Share by Manufacturers
3.1.3 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers
3.2.1 Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2016-2018)
3.2.2 Plasma Protease C1-inhibitor Treatment Revenue Share by Manufacturers (2016-2018)
3.3 Plasma Protease C1-inhibitor Treatment Price by Manufacturers
3.4 Plasma Protease C1-inhibitor Treatment Manufacturing Base Distribution, Product Types
3.4.1 Plasma Protease C1-inhibitor Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Plasma Protease C1-inhibitor Treatment Product Category
3.4.3 Date of International Manufacturers Enter into Plasma Protease C1-inhibitor Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Plasma Protease C1-inhibitor Treatment Sales by Type
4.2 Global Plasma Protease C1-inhibitor Treatment Revenue by Type
4.3 Plasma Protease C1-inhibitor Treatment Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Plasma Protease C1-inhibitor Treatment Breakdown Data by Application
6 North America
6.1 North America Plasma Protease C1-inhibitor Treatment by Countries
6.1.1 North America Plasma Protease C1-inhibitor Treatment Sales by Countries
6.1.2 North America Plasma Protease C1-inhibitor Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Plasma Protease C1-inhibitor Treatment by Type
6.3 North America Plasma Protease C1-inhibitor Treatment by Application
6.4 North America Plasma Protease C1-inhibitor Treatment by Company
7 Europe
7.1 Europe Plasma Protease C1-inhibitor Treatment by Countries
7.1.1 Europe Plasma Protease C1-inhibitor Treatment Sales by Countries
7.1.2 Europe Plasma Protease C1-inhibitor Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Plasma Protease C1-inhibitor Treatment by Type
7.3 Europe Plasma Protease C1-inhibitor Treatment by Application
7.4 Europe Plasma Protease C1-inhibitor Treatment by Company
8 Asia Pacific
8.1 Asia Pacific Plasma Protease C1-inhibitor Treatment by Countries
8.1.1 Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Countries
8.1.2 Asia Pacific Plasma Protease C1-inhibitor Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Plasma Protease C1-inhibitor Treatment by Type
8.3 Asia Pacific Plasma Protease C1-inhibitor Treatment by Application
8.4 Asia Pacific Plasma Protease C1-inhibitor Treatment by Company
9 Central & South America
9.1 Central & South America Plasma Protease C1-inhibitor Treatment by Countries
9.1.1 Central & South America Plasma Protease C1-inhibitor Treatment Sales by Countries
9.1.2 Central & South America Plasma Protease C1-inhibitor Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Plasma Protease C1-inhibitor Treatment by Type
9.3 Central & South America Plasma Protease C1-inhibitor Treatment by Application
9.4 Central & South America Plasma Protease C1-inhibitor Treatment by Company
10 Middle East and Africa
10.1 Middle East and Africa Plasma Protease C1-inhibitor Treatment by Countries
10.1.1 Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Countries
10.1.2 Middle East and Africa Plasma Protease C1-inhibitor Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Plasma Protease C1-inhibitor Treatment by Type
10.3 Middle East and Africa Plasma Protease C1-inhibitor Treatment by Application
10.4 Middle East and Africa Plasma Protease C1-inhibitor Treatment by Company
11 Company Profiles
11.1 Shire plc
11.1.1 Shire plc Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Plasma Protease C1-inhibitor Treatment
11.1.4 Plasma Protease C1-inhibitor Treatment Product Description
11.1.5 Recent Development
11.2 CSL Limited
11.2.1 CSL Limited Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Plasma Protease C1-inhibitor Treatment
11.2.4 Plasma Protease C1-inhibitor Treatment Product Description
11.2.5 Recent Development
11.3 Sanquin
11.3.1 Sanquin Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Plasma Protease C1-inhibitor Treatment
11.3.4 Plasma Protease C1-inhibitor Treatment Product Description
11.3.5 Recent Development
11.4 Pharming Group N.V.
11.4.1 Pharming Group N.V. Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Plasma Protease C1-inhibitor Treatment
11.4.4 Plasma Protease C1-inhibitor Treatment Product Description
11.4.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Plasma Protease C1-inhibitor Treatment Raw Material
13.1.2 Plasma Protease C1-inhibitor Treatment Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Plasma Protease C1-inhibitor Treatment
Figure Global Plasma Protease C1-inhibitor Treatment Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Production Market Share by Types (Product Category) in 2017
Figure C1-inhibitors Product Picture
Table Major Manufacturers of C1-inhibitors
Figure Kallikrein Inhibitor (Kalbitor) Product Picture
Table Major Manufacturers of Kallikrein Inhibitor (Kalbitor)
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Product Picture
Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist (Firazyr)
Table Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital Pharmacies
Figure Independent Pharmacies and Outlets
Figure Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure Global Plasma Protease C1-inhibitor Treatment Market Size 2016-2025 (Million US$)
Figure Global Plasma Protease C1-inhibitor Treatment Sales 2016-2025 (K Units)
Table Global Plasma Protease C1-inhibitor Treatment Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Sales by Regions 2016-2025 (K Units)
Table Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Regions 2016-2025
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Regions 2016-2025
Figure 2017 Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Regions
Table Global Plasma Protease C1-inhibitor Treatment Revenue by Regions 2016-2025 (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Regions 2016-2025
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Regions 2016-2025
Figure 2017 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Regions
Table Global Plasma Protease C1-inhibitor Treatment Sales by Manufacturers (2016-2018) (K Units)
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Manufacturers (2016-2018)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Share by Manufacturers in 2017
Table Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2016-2018) (Million US$)
Table Plasma Protease C1-inhibitor Treatment Revenue Share by Manufacturers (2016-2018)
Figure Plasma Protease C1-inhibitor Treatment Value Share by Manufacturers in 2017
Table Global Plasma Protease C1-inhibitor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Plasma Protease C1-inhibitor Treatment Price (2016-2018) (USD/Unit)
Table Plasma Protease C1-inhibitor Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Plasma Protease C1-inhibitor Treatment Product Category
Table Date of International Manufacturers Enter into Plasma Protease C1-inhibitor Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Plasma Protease C1-inhibitor Treatment Sales by Type (2016-2025) (K Units)
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Type (2016-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2016-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Type in 2017
Table Global Plasma Protease C1-inhibitor Treatment Revenue by Type (2016-2025) (Million US$)
Table Global Plasma Protease C1-inhibitor Treatment Revenue Share by Type (2016-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2016-2025)
Figure Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type in 2017
Table Plasma Protease C1-inhibitor Treatment Price by Type 2013-2018 (USD/Unit)
Table Global Plasma Protease C1-inhibitor Treatment Sales by Application (2016-2025) (K Units)
Table Global Plasma Protease C1-inhibitor Treatment Sales Share by Application (2016-2025)
Figure Global Sales Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2025)
Figure Global Sales Plasma Protease C1-inhibitor Treatment Market Share by Application (2016-2025)
Figure North America Plasma Protease C1-inhibitor Treatment Sales Growth Rate 2016-2025 (K Units)
Figure North America Plasma Protease C1-inhibitor Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table North America Plasma Protease C1-inhibitor Treatment Sales by Countries (2016-2025) (K Units)
Table North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries
Table North America Plasma Protease C1-inhibitor Treatment Revenue by Countries (2016-2025) (Million US$)
Table North America Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries
Figure United States Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure United States Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Canada Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table North America Plasma Protease C1-inhibitor Treatment Sales by Type (2016-2025) (K Units)
Table North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2016-2025)
Figure 2017 North America Plasma Protease C1-inhibitor Treatment Market Share by Type
Table North America Plasma Protease C1-inhibitor Treatment Sales by Application (2016-2025) (K Units)
Table North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2016-2025)
Figure 2017 North America Plasma Protease C1-inhibitor Treatment Market Share by Application
Table North America Plasma Protease C1-inhibitor Treatment Sales by Company (2016-2018) (K Units)
Table North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2016-2018)
Figure North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2017
Figure Europe Plasma Protease C1-inhibitor Treatment Sales Growth Rate 2016-2025 (K Units)
Figure Europe Plasma Protease C1-inhibitor Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Plasma Protease C1-inhibitor Treatment Sales by Countries (2016-2025) (K Units)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries
Table Europe Plasma Protease C1-inhibitor Treatment Revenue by Countries (2016-2025) (Million US$)
Table Europe Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries
Figure Germany Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Germany Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (K Units)
Figure France Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure France Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (K Units)
Figure UK Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure UK Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Italy Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Russia Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Plasma Protease C1-inhibitor Treatment Sales by Type (2016-2025) (K Units)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Europe Plasma Protease C1-inhibitor Treatment Market Share by Type
Table Europe Plasma Protease C1-inhibitor Treatment Sales by Application (2016-2025) (K Units)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Europe Plasma Protease C1-inhibitor Treatment Market Share by Application
Table Europe Plasma Protease C1-inhibitor Treatment Sales by Company (2016-2018) (K Units)
Table Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2016-2018)
Figure Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2017
Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries
Figure China Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure China Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Japan Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Korea Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure India Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure India Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Australia Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Type (2016-2025) (K Units)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Plasma Protease C1-inhibitor Treatment Market Share by Type
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Application (2016-2025) (K Units)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Plasma Protease C1-inhibitor Treatment Market Share by Application
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Company (2016-2018) (K Units)
Table Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2016-2018)
Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2017
Figure Central & South America Plasma Protease C1-inhibitor Treatment Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Plasma Protease C1-inhibitor Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales by Countries (2016-2025) (K Units)
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries
Table Central & South America Plasma Protease C1-inhibitor Treatment Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries
Figure Brazil Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales by Type (2016-2025) (K Units)
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Type
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales by Application (2016-2025) (K Units)
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Application
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales by Company (2016-2018) (K Units)
Table Central & South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2016-2018)
Figure Central & South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2017
Figure Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Plasma Protease C1-inhibitor Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Countries
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Plasma Protease C1-inhibitor Treatment Revenue Market Share by Countries
Figure GCC Countries Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Plasma Protease C1-inhibitor Treatment Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Plasma Protease C1-inhibitor Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Share by Type
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Share by Application
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Company in 2017
Table Shire plc Company Details
Table Shire plc Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Shire plc Recent Development
Table CSL Limited Company Details
Table CSL Limited Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table CSL Limited Recent Development
Table Sanquin Company Details
Table Sanquin Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanquin Recent Development
Table Pharming Group N.V. Company Details
Table Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pharming Group N.V. Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Plasma Protease C1-inhibitor Treatment Value Chain
Table Typical Suppliers of Key Plasma Protease C1-inhibitor Treatment Raw Material
Table Plasma Protease C1-inhibitor Treatment Customers List
Table Plasma Protease C1-inhibitor Treatment Sales Channels
Table Plasma Protease C1-inhibitor Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global White Willow Bark Extract Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 117
    White willow bark is used for the treatment of pain such as lower back and osteoarthritis in regions of Asia and Europe. Scope of the Report: White willow bark extract is slowly gaining popularity and is expected to show a steady increase in the revenue growth. The worldwide market for White Willow Bark Extract is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR ......
  • Global Wintergreen Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Wintergreen oil is of high importance and has a high reputation since ages as it possesses various therapeutic properties such as anti-rheumatic, anti-arthritic, antiseptic, aromatic, analgesic properties, etc. Scope of the Report: Due to change in the market trend, people are more interested in natural products which will play an important role in fueling the growth of present Wintergreen Oil Market. The worldwide market for Wintergreen Oil is expected to grow at a ......
  • Global Irritable Bowel Syndrome Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms. Scope of the Report: Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowe......
  • Global Peppermint Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Peppermint Oil is the oil that is extracted from the stem and flowers of the peppermint herb. Scope of the Report: This report focuses on the Peppermint Oil in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Peppermint Oil is expected to grow at a CAGR of roughly xx% over the next five years, wi......
  • Global Dermal Adhesives Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    A dermal adhesive (or skin glue) is a glue used to close wounds in the skin, as an alternative to sutures, staples or clips. Scope of the Report: Glued closure produces less scarring and is less prone to infection than sutured or stapled closure. There is also no residual closure to remove, so follow-up visits for removal are not required. The factor that contributes to the growth of the global Skin Glue market is the rising number of traumatic injuries. The market g......
  • Global Skin Glue Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 123
    A dermal adhesive (or skin glue) is a glue used to close wounds in the skin, as an alternative to sutures, staples or clips. Scope of the Report: Glued closure produces less scarring and is less prone to infection than sutured or stapled closure. There is also no residual closure to remove, so follow-up visits for removal are not required. The factor that contributes to the growth of the global Skin Glue market is the rising number of traumatic injuries. The market g......
  • Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help......
  • Global Alpha Glucosidase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day. ......
  • Global Cancer Pain Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response. Scope of the Report: The report, states that opioids will continue to dominate as a breakthrough cancer pain treatment, mostly due to available generics and physician familiarity. The worldwide market for Cancer Pain is expected to grow at a CAGR of roughly xx......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs